Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1982 4
1983 6
1984 3
1985 4
1986 4
1987 2
1988 1
1989 3
1990 2
1991 3
1992 5
1993 3
1994 2
1995 2
1996 3
1998 1
1999 2
2002 2
2003 3
2004 2
2005 6
2006 3
2007 2
2008 8
2009 6
2010 10
2011 13
2012 6
2013 7
2014 9
2015 7
2016 5
2017 11
2018 9
2019 14
2020 10
2021 12
2022 4
2023 6
2024 10
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

199 results

Results by year

Filters applied: . Clear all
Page 1
Αlpha-thalassemia: A practical overview.
Musallam KM, Cappellini MD, Coates TD, Kuo KHM, Al-Samkari H, Sheth S, Viprakasit V, Taher AT. Musallam KM, et al. Among authors: coates td. Blood Rev. 2024 Mar;64:101165. doi: 10.1016/j.blre.2023.101165. Epub 2024 Jan 3. Blood Rev. 2024. PMID: 38182489 Free article. Review.
Higher hemoglobin is better in thalassemia.
Coates TD. Coates TD. Blood. 2024 Mar 7;143(10):842-844. doi: 10.1182/blood.2023023294. Blood. 2024. PMID: 38451517 Free article. No abstract available.
Introduction to a review series on human neutrophils.
Berliner N, Coates TD. Berliner N, et al. Among authors: coates td. Blood. 2019 May 16;133(20):2111-2112. doi: 10.1182/blood-2019-01-891770. Epub 2019 Mar 21. Blood. 2019. PMID: 30898861 Free article. No abstract available.
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial.
Taher AT, Cappellini MD, Kattamis A, Voskaridou E, Perrotta S, Piga AG, Filosa A, Porter JB, Coates TD, Forni GL, Thompson AA, Tartaglione I, Musallam KM, Backstrom JT, Esposito O, Giuseppi AC, Kuo WL, Miteva D, Lord-Bessen J, Yucel A, Zinger T, Shetty JK, Viprakasit V; BEYOND Investigators. Taher AT, et al. Among authors: coates td. Lancet Haematol. 2022 Oct;9(10):e733-e744. doi: 10.1016/S2352-3026(22)00208-3. Epub 2022 Aug 22. Lancet Haematol. 2022. PMID: 36007538 Clinical Trial.
Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trial.
Cappellini MD, Viprakasit V, Georgiev P, Coates TD, Origa R, Khelif A, Liew HK, Tantiworawit A, Chew LP, Khalil A, Ho PJ, Kuo KHM, Holot N, Perin M, Giuseppi AC, Kuo WL, Lai Y, Medlin LF, Bueno LM, Kattamis A, Taher AT. Cappellini MD, et al. Among authors: coates td. Lancet Haematol. 2025 Mar;12(3):e180-e189. doi: 10.1016/S2352-3026(24)00376-4. Epub 2025 Feb 10. Lancet Haematol. 2025. PMID: 39947215 Clinical Trial.
199 results